European equities traded in the US as American depositary receipts were falling Friday morning, down 1.3% to 1,489.59 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech company Cellectis (CLLS) and oil and gas company Equinor (EQNR), which rose 4.6% and 4.1%, respectively.

They were followed by late-stage biopharmaceutical company Genfit (GNFT), which was up 2.9%.

The decliners from continental Europe were led by biotech company Evaxion (EVAX) and cybersecurity firm Wisekey (WKEY), which fell 5.9% and 5.2%, respectively.

They were followed by biotech company Abivax (ABVX), down 5.1%, and semiconductor company ASML (ASML), shedding 2.8%.

From the UK and Ireland, the gainers were led by energy giant BP (BP) and cigarette company British American Tobacco (BTI), which rose 2.1% and 1%, respectively.

The decliners from the UK and Ireland were led by cruise operator Carnival (CUK) and biotech company Bicycle Therapeutics (BCYC), which were shedding 4.5% and 4.3%, respectively.